Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Price RB, Shungu DC, Mao X, Nestadt P, Kelly C, Collins KA, Murrough JW, Charney DS, Mathew SJ.

Biol Psychiatry. 2009 May 1;65(9):792-800. doi: 10.1016/j.biopsych.2008.10.025. Epub 2008 Dec 5.

2.

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC.

Arch Gen Psychiatry. 2007 Feb;64(2):193-200.

PMID:
17283286
3.

Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.

Abdallah CG, Jackowski A, Sato JR, Mao X, Kang G, Cheema R, Coplan JD, Mathew SJ, Shungu DC.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1082-90. doi: 10.1016/j.euroneuro.2015.04.025. Epub 2015 May 5.

4.

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.

Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF.

Arch Gen Psychiatry. 2004 Jul;61(7):705-13.

PMID:
15237082
5.

Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia.

Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC.

Arch Gen Psychiatry. 2012 Feb;69(2):139-49. doi: 10.1001/archgenpsychiatry.2011.131. Epub 2011 Oct 3.

6.

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.

Salvadore G, van der Veen JW, Zhang Y, Marenco S, Machado-Vieira R, Baumann J, Ibrahim LA, Luckenbaugh DA, Shen J, Drevets WC, Zarate CA Jr.

Int J Neuropsychopharmacol. 2012 Sep;15(8):1063-72. doi: 10.1017/S1461145711001593. Epub 2011 Nov 1.

7.

Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.

Simpson HB, Shungu DC, Bender J Jr, Mao X, Xu X, Slifstein M, Kegeles LS.

Neuropsychopharmacology. 2012 Nov;37(12):2684-92. doi: 10.1038/npp.2012.132. Epub 2012 Aug 1.

8.

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.

9.

Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?

Plante DT, Jensen JE, Schoerning L, Winkelman JW.

Neuropsychopharmacology. 2012 May;37(6):1548-57. doi: 10.1038/npp.2012.4. Epub 2012 Feb 8.

10.

Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study.

Moore CM, Wardrop M, deB Frederick B, Renshaw PF.

Psychopharmacology (Berl). 2006 Oct;188(2):236-43. Epub 2006 Aug 31. Erratum in: Psychopharmacology (Berl). 2007 Feb;190(3):401-2.

PMID:
16944105
11.

Decreased occipital cortical glutamate levels in response to successful cognitive-behavioral therapy and pharmacotherapy for major depressive disorder.

Abdallah CG, Niciu MJ, Fenton LR, Fasula MK, Jiang L, Black A, Rothman DL, Mason GF, Sanacora G.

Psychother Psychosom. 2014;83(5):298-307. doi: 10.1159/000361078. Epub 2014 Aug 6.

12.

Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.

Hasler G, Neumeister A, van der Veen JW, Tumonis T, Bain EE, Shen J, Drevets WC, Charney DS.

Biol Psychiatry. 2005 Dec 15;58(12):969-73. Epub 2005 Jul 25.

PMID:
16043137
13.

Alterations of GABA and glutamate-glutamine levels in premenstrual dysphoric disorder: a 3T proton magnetic resonance spectroscopy study.

Liu B, Wang G, Gao D, Gao F, Zhao B, Qiao M, Yang H, Yu Y, Ren F, Yang P, Chen W, Rae CD.

Psychiatry Res. 2015 Jan 30;231(1):64-70. doi: 10.1016/j.pscychresns.2014.10.020. Epub 2014 Nov 5.

PMID:
25465316
14.

Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.

Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P.

Biol Psychiatry. 2005 Nov 1;58(9):700-4. Epub 2005 Aug 8.

PMID:
16084860
15.

Anterior cingulate Glutamate-Glutamine cycle metabolites are altered in euthymic bipolar I disorder.

Soeiro-de-Souza MG, Henning A, Machado-Vieira R, Moreno RA, Pastorello BF, da Costa Leite C, Vallada H, Otaduy MC.

Eur Neuropsychopharmacol. 2015 Dec;25(12):2221-9. doi: 10.1016/j.euroneuro.2015.09.020. Epub 2015 Oct 9.

PMID:
26476706
16.

Anterior cingulate cortex and cerebellar hemisphere neurometabolite changes in depression treatment: A 1H magnetic resonance spectroscopy study.

Chen LP, Dai HY, Dai ZZ, Xu CT, Wu RH.

Psychiatry Clin Neurosci. 2014 May;68(5):357-64. doi: 10.1111/pcn.12138. Epub 2014 Jan 7.

17.

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F.

Biol Psychiatry. 2000 Feb 15;47(4):305-13.

PMID:
10686265
18.

The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

Walter M, Henning A, Grimm S, Schulte RF, Beck J, Dydak U, Schnepf B, Boeker H, Boesiger P, Northoff G.

Arch Gen Psychiatry. 2009 May;66(5):478-86. doi: 10.1001/archgenpsychiatry.2009.39.

PMID:
19414707
19.

Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.

Masaki C, Sharpley AL, Godlewska BR, Berrington A, Hashimoto T, Singh N, Vasudevan SR, Emir UE, Churchill GC, Cowen PJ.

Psychopharmacology (Berl). 2016 Mar;233(6):1097-104. doi: 10.1007/s00213-015-4189-2. Epub 2016 Jan 12.

20.

Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.

Ongür D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM, Renshaw PF.

Biol Psychiatry. 2008 Oct 15;64(8):718-26. doi: 10.1016/j.biopsych.2008.05.014. Epub 2008 Jul 7.

Supplemental Content

Support Center